Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > RJFK Jr will love our company
View:
Post by Sosak1 on Nov 15, 2024 5:00pm

RJFK Jr will love our company

Comment by Habeneropie on Nov 15, 2024 5:08pm
Lets hope he loves TLT i doubt its on his radar. He is more focused on random wild animalls that might run over in his car and take home!   LOL Lets hope
Comment by skier59 on Nov 15, 2024 7:02pm
This actually couldn't come at a worst time for us. I see more delays unfortunately.
Comment by Longholder99 on Nov 15, 2024 8:12pm
I see us progressing to market with an FDA approval for BTD upcoming well before January.  That said, if I was backing some immuno-franken drug that works on 20% of the people 40% of the time.  You're probably right.  Beyond that we all get to watch this Board be polluted with scare tactics and head fakes in the interim. Do your own DD.....don't make investment decisions ...more  
Comment by Infinity on Nov 15, 2024 9:46pm
IMO,  Secretary of health makes the Policy decisions on using the Health budget wisely to stretch the reach to more people more efficiently at lower costs.  They do not run the FDA nor does RFK have the skill sets to run an agency that is to a large extent influenced by Big Pharma who also contribute heavily to election funds to make sure that they retain the political clout over their ...more  
Comment by skier59 on Nov 16, 2024 7:28am
To be honest, almost all of orange face cabinet picks lack any skill sets for the jobs proposed. They have said they intend on massive cuts and retribution throughout the USA government, and the FDA is part of their plans. Everyone working in public service is extremely concerned for their futures. If orange face pushes these through without regular senate confirmations, and operates as a dictator ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250